Anyone who has struggled with sleep for years knows how appealing a simple solution can be. Supplements are marketed for falling asleep faster, staying asleep longer, increasing deep sleep, improving REM sleep and waking refreshed.
Unfortunately, marketing claims often move faster than scientific research. Some ingredients have encouraging small studies. Others have little direct human evidence. And some commonly used over-the-counter sleep medications have risks that deserve much more attention.
Research reviewed through November 2026. Study doses are provided as research context, not instructions to take those amounts.
Five Questions Before You Try a Sleep Supplement
- What problem am I trying to solve? Falling asleep, waking at night, circadian timing, poor sleep quality and daytime fatigue are different concerns.
- What evidence applies to that problem? A study involving stress in healthy volunteers does not establish a treatment for chronic insomnia.
- What is in the product? Check the active ingredient, actual amount, serving size, formulation and other ingredients.
- Could it interact with my medicines? Prescription drugs, other supplements, alcohol and medical conditions can change the risk considerably.
- How will I evaluate the result? Look at sleep and next-day functioning. Avoid introducing several new products simultaneously.
Seven Common Sleep Supplements and Aids
Each ingredient below has its own detailed section, including research, possible benefits, side effects, interactions and a practical conclusion.
1. Melatonin
The body's natural nighttime timing signal
What is melatonin?
Melatonin is a hormone produced primarily by the pineal gland. Its secretion normally increases in dim light during the evening, helping coordinate the body's internal circadian clock.
Melatonin does not function exactly like a conventional sleeping pill. Its main biological role is communicating nighttime to the body. This helps explain why timing can matter as much as the amount taken.
What does the research show?
Melatonin has evidence supporting its use in certain circadian-rhythm disorders, particularly delayed sleep-wake phase disorder. It may also help with jet lag.
Some studies find modest reductions in the time required to fall asleep. Evidence for chronic insomnia, particularly repeated awakenings during the night, is less convincing.
Professional insomnia guidelines do not recommend melatonin as a routine treatment for chronic insomnia in adults because convincing evidence of meaningful benefit is insufficient.
A randomized trial involving people with delayed sleep-wake phase disorder found that appropriately timed melatonin combined with scheduled sleep timing improved sleep onset.
This finding should not be generalized to every form of insomnia.
What about dosage?
Research uses different amounts depending on the condition and formulation. Larger doses do not necessarily work better. Some people experience lingering drowsiness from higher doses.
Immediate-release and prolonged-release products may produce different effects. Their results should not be assumed interchangeable.
Potential benefits beyond ordinary insomnia
- Helping shift sleep timing in selected circadian disorders.
- Reducing certain symptoms of jet lag.
- Possible usefulness for some shift-work schedules, with mixed evidence.
- Biological antioxidant activity, although supplemental clinical benefits remain uncertain.
Possible side effects
- Morning grogginess or daytime sleepiness.
- Headache or dizziness.
- Nausea.
- Vivid dreams or nightmares.
- Occasional irritability or restlessness.
2. Magnesium
An essential mineral involved in nerve, muscle and metabolic function
What is magnesium?
Magnesium is essential for hundreds of biochemical reactions. It supports normal nerve signaling, muscle contraction, energy production, bone health and cardiovascular function.
Magnesium is commonly promoted for relaxation and sleep. However, its importance to normal physiology does not mean that additional magnesium improves sleep in someone whose intake is already adequate.
What does the research show?
Earlier systematic reviews found limited and inconsistent evidence that magnesium supplementation improves insomnia. Many trials were small or had methodological limitations.
A 2025 randomized, double-blind, placebo-controlled trial studied 155 adults reporting poor sleep. Participants received magnesium bisglycinate providing 250 mg of elemental magnesium daily or placebo for four weeks.
Insomnia Severity Index scores improved somewhat more with magnesium than placebo. The effect was statistically significant but small.
Average insomnia severity scores improved by approximately 3.9 points with magnesium compared with 2.3 points with placebo.
The reported effect size was small (Cohen's d = 0.2). Exploratory findings suggested greater improvement might occur in people with lower dietary magnesium intake.
Which type of magnesium?
Different forms have different absorption and gastrointestinal characteristics.
- Magnesium glycinate/bisglycinate: Often marketed as gentle on digestion. A 2025 trial provides some direct sleep-related evidence, but not proof of superiority over other forms.
- Magnesium citrate: Generally well absorbed but may have a laxative effect.
- Magnesium oxide: Contains substantial elemental magnesium by weight but is generally less well absorbed than some other forms.
- Magnesium L-threonate: Marketed for cognitive health. Claims about superior brain penetration or sleep benefits require stronger clinical evidence.
Other benefits
- Correcting inadequate magnesium intake or deficiency.
- Supporting normal nerve and muscle function.
- Contributing to bone health.
- Supporting normal blood pressure regulation.
- Participating in glucose metabolism and energy production.
These are established roles of magnesium, not proof that supplementation produces additional benefits when magnesium status is already sufficient.
Possible side effects
- Diarrhea.
- Abdominal cramps.
- Nausea.
- Excessive magnesium accumulation in kidney disease.
- At toxic levels, weakness, low blood pressure and potentially dangerous cardiac effects.
3. Apigenin
A flavonoid found in chamomile, parsley and other plants
What is apigenin?
Apigenin is a naturally occurring plant flavonoid found in chamomile, parsley, celery and several other foods.
It has attracted interest because laboratory experiments suggest interactions with signaling systems involved in relaxation, including GABA-related pathways.
What does the research show?
The distinction between apigenin and chamomile is essential.
Many human sleep studies have investigated chamomile preparations, not purified apigenin. Chamomile contains numerous biologically active compounds.
Therefore, even when chamomile produces a favorable result, researchers cannot automatically attribute that benefit to apigenin.
Reviews have described interesting laboratory mechanisms and preliminary clinical observations, but there is not convincing human evidence that isolated apigenin capsules treat chronic insomnia.
A 2024 review examined apigenin's possible roles in sleep and aging. Much of the mechanistic evidence came from laboratory or animal work, while human studies frequently involved whole chamomile preparations.
Possible benefits beyond sleep
- Antioxidant activity observed in laboratory studies.
- Potential anti-inflammatory activity under investigation.
- Possible effects on cellular signaling.
- Research interest in neurological aging.
These findings do not establish that taking apigenin supplements prevents disease or improves long-term health.
Possible side effects and uncertainties
- Digestive discomfort may occur.
- Allergic reactions are possible with plant-derived preparations.
- Human long-term safety data for concentrated apigenin are limited.
- Potential interactions with medicines are insufficiently studied.
4. Glycine
An amino acid involved in neurotransmission and metabolism
What is glycine?
Glycine is an amino acid naturally produced by the body and obtained through food.
It participates in protein synthesis, collagen production, glutathione formation and nervous-system signaling.
Glycine can act as an inhibitory neurotransmitter in certain nervous-system pathways and also participates in NMDA-receptor signaling.
Why might glycine affect sleep?
Researchers have investigated whether glycine influences body-temperature regulation and the physiological transition into sleep.
The body normally undergoes temperature-related changes around sleep onset. Some experimental work suggests glycine may influence pathways involved in those changes.
What do human studies show?
Several small studies investigated approximately 3 grams of glycine before bedtime.
Some reported improvements in subjective sleep quality, morning fatigue and feelings of next-day alertness.
Earlier laboratory research also reported effects on certain sleep-onset measures, although it did not establish large improvements across every component of sleep architecture.
Importantly, evidence does not establish that glycine reliably increases total deep sleep or treats chronic insomnia.
Small human trials have reported improvements in subjective sleep quality and next-day functioning under certain experimental conditions.
The results are interesting, but the number of participants and independent replications remains limited.
Other biological roles and possible benefits
- Formation of collagen and other proteins.
- Participation in glutathione synthesis.
- Normal neurotransmitter signaling.
- Metabolic pathways involving creatine and other compounds.
- Possible improvements in subjective fatigue in small sleep studies.
These roles are well established physiologically, but supplemental health benefits are not necessarily established for otherwise healthy individuals.
Possible side effects
- Nausea or stomach discomfort.
- Soft stools or other gastrointestinal symptoms.
- Occasional headache or unusual subjective effects.
- Uncertain long-term effects at supplemental doses.
5. L-Ornithine
An amino acid involved in the urea cycle and ammonia metabolism
What is L-ornithine?
L-ornithine is a non-protein amino acid produced naturally by the body.
It plays an important role in the urea cycle, which helps the liver convert potentially harmful ammonia into urea for elimination.
Ornithine has also been studied for possible effects on stress, fatigue and sleep quality.
What does the research show?
A randomized, double-blind, placebo-controlled study published in 2014 investigated 52 Japanese adults reporting mild stress and fatigue.
Participants received 400 mg of L-ornithine daily or placebo for eight weeks.
Researchers observed favorable changes in certain stress-related hormone measures and reported improvements in some subjective sleep and mood outcomes.
The study was small and did not establish that ornithine treats chronic insomnia or sleep apnea.
The study found reductions in cortisol-related measures and improvements in perceived sleep quality and anger in the ornithine group.
These findings support further investigation, not a definitive treatment recommendation.
Why might it affect sleep?
One hypothesis is that ornithine may influence stress physiology.
Stress and heightened physiological arousal can interfere with sleep. However, the precise mechanism by which oral ornithine might improve sleep remains uncertain.
Other biological roles and potential benefits
- Participation in normal ammonia disposal.
- Contribution to urea-cycle function.
- Possible effects on perceived stress and fatigue.
- Participation in pathways related to polyamine synthesis.
L-ornithine should not be confused with the medically studied combination L-ornithine L-aspartate, which has been investigated in specific liver-related conditions.
Findings involving that medical combination cannot automatically be applied to ordinary ornithine supplements.
Possible side effects
- Nausea or digestive discomfort.
- Diarrhea at some doses.
- Headache or other nonspecific symptoms.
- Unknown long-term safety with regular supplementation.
6. Taurine
A sulfur-containing compound involved in cellular regulation
What is taurine?
Taurine is a sulfur-containing amino sulfonic acid found naturally in the body and in foods such as fish, meat and dairy.
It participates in several physiological processes, including bile-acid conjugation, osmoregulation, calcium signaling and cellular membrane stability.
Taurine is sometimes marketed for relaxation and sleep, partly because of laboratory findings involving inhibitory neurotransmitter systems.
What does the sleep research show?
Taurine has been studied in laboratory and animal experiments involving nervous-system activity and sleep-related pathways.
However, convincing randomized human trials demonstrating that taurine alone improves chronic insomnia are lacking.
Studies of energy drinks or multi-ingredient products do not isolate taurine's effects. Such products may also contain caffeine, which complicates sleep interpretation.
Taurine has biologically plausible effects on nervous-system signaling, but evidence from experimental mechanisms should not be mistaken for demonstrated treatment benefits in people with insomnia.
Other possible benefits
- Normal bile-acid metabolism.
- Participation in cardiovascular and cellular physiology.
- Potential effects on exercise-related outcomes under investigation.
- Possible metabolic effects being studied in humans.
- Roles in retinal and nervous-system function.
These biological functions do not establish that taurine supplementation prevents disease or improves sleep.
Possible side effects and uncertainties
- Digestive upset.
- Headache or dizziness in some users.
- Possible blood-pressure effects that may matter in susceptible individuals.
- Incomplete information about long-term high-dose safety.
7. Unisom and Sedating Antihistamines
Over-the-counter sleep medications with important safety considerations
First, what exactly is Unisom?
Unisom is a brand name, not one specific drug. Different Unisom products contain different active ingredients.
| Product | Active ingredient | Important distinction |
|---|---|---|
| Unisom SleepTabs | Doxylamine succinate | First-generation antihistamine with strong anticholinergic effects. |
| Unisom SleepGels | Diphenhydramine hydrochloride | Different first-generation antihistamine; also strongly anticholinergic. |
| Other Unisom products | Varies by formulation | Always check the current Drug Facts or Supplement Facts label. |
Doxylamine and diphenhydramine are also found in some combination cold, allergy and nighttime products.
Taking multiple products without checking their ingredients can unintentionally duplicate exposure.
How do these medications cause sleepiness?
Both drugs are first-generation antihistamines. They cross into the brain and block histamine H1 receptors.
Histamine helps maintain wakefulness. Blocking its action can produce drowsiness.
But these medications also block certain acetylcholine receptors. This is called an anticholinergic effect.
Anticholinergic activity contributes to several important side effects beyond simple sedation.
What does the sleep research show?
These medications can produce short-term drowsiness, but high-quality evidence supporting sustained benefits for chronic insomnia is insufficient.
Tolerance to their sedating effects can develop. This means the same amount may become less effective over repeated use.
The American Academy of Sleep Medicine recommends against diphenhydramine for chronic insomnia because of limited evidence of benefit.
Neither doxylamine nor diphenhydramine should be regarded as a proven long-term sleep-maintenance treatment.
Possible short-term effects
- Sleepiness and sedation.
- Possible reduction in difficulty falling asleep.
- Next-morning grogginess.
- Slower reaction time and reduced coordination.
- Impaired attention and concentration.
Common anticholinergic side effects
- Dry mouth.
- Constipation.
- Blurred vision.
- Difficulty urinating or urinary retention.
- Reduced sweating and heat intolerance.
- Confusion, particularly in older adults.
- Dizziness and increased fall risk.
Why older adults deserve special caution
The American Geriatrics Society's 2023 Beers Criteria recommend avoiding first-generation antihistamines such as diphenhydramine and doxylamine in most older adults.
The concerns include reduced drug clearance, strong anticholinergic activity, confusion, constipation, falls and possible cognitive harm.
This is especially important because these medicines are available without a prescription.
The American Geriatrics Society identifies diphenhydramine and doxylamine as highly anticholinergic medications that should generally be avoided in older adults.
Other medical concerns
- Glaucoma: Anticholinergic effects may be particularly concerning in people with narrow-angle glaucoma. Discuss use with an eye-care professional.
- Prostate enlargement: These medicines may worsen urinary hesitancy or retention.
- Breathing disorders: People with significant respiratory disease or possible sleep apnea should seek medical guidance.
- Alcohol and sedatives: Combining sedating products can increase impairment.
- Driving: Residual impairment may persist into the following day.
Understanding Anticholinergic Effects: Why They Matter
This is one of the most important safety topics in the entire guide.
Some medications sold for sleep, allergies, motion sickness, bladder symptoms and other conditions have anticholinergic properties.
A person may take several of these medications without realizing they affect the same neurotransmitter system.
What does anticholinergic mean?
Acetylcholine is a neurotransmitter involved in memory, attention, learning, muscle activity and the regulation of internal organs.
Anticholinergic drugs block some of acetylcholine's actions, particularly at muscarinic receptors.
This can affect the brain, eyes, digestive tract, bladder, heart and sweat glands.
Short-term effects
Common anticholinergic effects include:
- Dry mouth: Reduced saliva production.
- Constipation: Slower intestinal movement.
- Urinary retention: Difficulty emptying the bladder.
- Blurred vision: Effects on eye focusing and pupil function.
- Reduced sweating: Increased risk of overheating.
- Confusion: Particularly in susceptible older adults.
- Memory and attention problems: Possible short-term cognitive impairment.
- Falls: Sedation, dizziness and confusion can increase risk.
Severe anticholinergic toxicity can cause agitation, hallucinations, dangerously elevated body temperature, rapid heart rate, urinary retention and delirium.
Suspected severe toxicity requires urgent medical care.
What is anticholinergic burden?
Anticholinergic burden refers to the combined anticholinergic effects of all the medications a person takes.
For example, someone might use a sedating antihistamine at night, a bladder medication during the day, and an antidepressant with anticholinergic properties.
Even if each medicine was prescribed for a different reason, the combined exposure may increase side effects.
Pharmacists and clinicians sometimes use structured anticholinergic burden scales to identify potential problems. These scales differ and are screening aids, not precise measurements of individual risk.
Which other medicines may contribute?
| Medication category | Examples | Why review them? |
|---|---|---|
| First-generation antihistamines | Diphenhydramine, doxylamine, hydroxyzine | Strong anticholinergic activity; sedation and confusion. |
| Some antidepressants | Amitriptyline, nortriptyline, paroxetine | May contribute to cumulative anticholinergic exposure. |
| Some bladder medications | Oxybutynin, tolterodine | Can add anticholinergic effects; risks vary by medication. |
| Some motion-sickness medications | Scopolamine, meclizine | May affect alertness and anticholinergic burden. |
| Some muscle relaxants | Cyclobenzaprine | Can cause sedation and anticholinergic effects. |
These are examples, not a complete list. Risk depends on the specific medication, dose, duration and individual circumstances.
What about dementia?
Long-term anticholinergic exposure has been investigated in several observational studies.
A particularly influential study published in JAMA Internal Medicine in 2015 followed 3,434 adults aged 65 and older.
Researchers examined cumulative exposure to strong anticholinergic medications over time.
Compared with people without such exposure, those in the highest cumulative-exposure category had a statistically significant increase in dementia diagnoses.
The highest cumulative exposure category was associated with an adjusted hazard ratio of approximately 1.54 for dementia compared with nonuse.
That corresponds to a 54% higher relative rate in this study, not a 54% absolute probability of dementia.
Does that mean anticholinergic drugs cause dementia?
Not necessarily.
The study was observational. It identified an association, but could not prove that the medications themselves caused dementia.
Other factors may contribute, including the underlying conditions being treated, differences in health status and unmeasured confounding.
Research also has difficulty separating medication effects from early symptoms of conditions that later lead to dementia diagnoses.
Nevertheless, the findings are important because anticholinergic medications have well-established short-term cognitive effects, and cumulative exposure may be avoidable in some cases.
Why are older adults more vulnerable?
- Some medications remain in the body longer as clearance changes with age.
- The brain may be more sensitive to medication-related confusion.
- Multiple prescriptions increase the possibility of cumulative exposure.
- Falls and fractures can have more serious consequences.
- Existing memory problems may become worse with certain medications.
What should someone do if they take one regularly?
- Identify the exact active ingredient and amount.
- Review all prescription and over-the-counter medicines for overlapping anticholinergic effects.
- Ask a pharmacist or clinician whether the medicine is still needed.
- Discuss safer alternatives for the condition being treated.
- Do not abruptly discontinue prescribed medications without appropriate guidance.
How Do These Ingredients Compare?
| Ingredient | Current sleep evidence | Main limitation or concern |
|---|---|---|
| Melatonin | Useful for certain circadian-timing problems. | Less convincing for chronic insomnia and repeated awakenings. |
| Magnesium | Mixed research; modest benefit in a 2025 trial. | Benefit may be small; kidney function and interactions matter. |
| Apigenin | Preliminary mechanisms and chamomile-related studies. | Insufficient trials of isolated apigenin. |
| Glycine | Small human studies suggest possible sleep-quality benefits. | Limited replication and long-term evidence. |
| L-Ornithine | One small randomized trial found favorable stress and sleep outcomes. | Insufficient evidence for chronic insomnia. |
| Taurine | Biological rationale, little convincing direct human sleep evidence. | Effectiveness and long-term safety remain uncertain. |
| Unisom antihistamines | Can cause short-term sedation. | Anticholinergic effects, next-day impairment and poor suitability for long-term use. |
Supplement Quality: What Is Actually in the Bottle?
Dietary supplements are regulated differently from prescription drugs. Manufacturers generally do not need to demonstrate effectiveness for insomnia before marketing a supplement.
Important considerations include:
- Whether the listed amount matches the actual contents.
- Whether the product contains undisclosed ingredients.
- Whether the formulation has been independently tested.
- Whether the product includes several sedating ingredients.
- Whether the product's claims are supported by studies of that specific formulation.
What do third-party testing seals mean?
Programs such as USP verification and certain NSF certifications may provide reassurance about manufacturing quality and ingredient identity.
A quality seal does not establish that a supplement treats insomnia or is safe for every individual.
See the NIH Office of Dietary Supplements consumer guide for more information.
How to Evaluate Whether Something Is Helping
One challenge with sleep supplements is that sleep naturally varies from night to night.
A good night after taking something new does not prove the product caused it. Likewise, one bad night does not prove a supplement failed.
Track more than sleep stages
- Approximate bedtime and wake time.
- How long it took to fall asleep.
- How often you remember waking.
- How long you were awake during the night.
- How rested you felt in the morning.
- Daytime sleepiness and concentration.
- Possible side effects such as dizziness or grogginess.
Apple Watch and other wearables may help identify broad patterns, but their sleep-stage estimates are not precise enough to prove that a supplement increased deep sleep or REM sleep.
When Supplements Are Not the Answer
Persistent insomnia can have several contributing factors, including conditioned arousal, circadian misalignment, pain, medications, anxiety, sleep apnea and other medical conditions.
A supplement may temporarily change how someone feels without addressing the underlying cause.
CBT-I: A treatment with stronger evidence
Cognitive behavioral therapy for insomnia, or CBT-I, is a structured treatment that addresses behaviors and thought patterns that perpetuate chronic insomnia.
It is recommended as a first-line treatment for chronic insomnia in adults.
CBT-I is not simply generic sleep-hygiene advice. It involves targeted techniques such as stimulus control, individualized sleep scheduling and cognitive strategies.
Persistent snoring, gasping, witnessed breathing pauses or significant daytime sleepiness warrant medical evaluation rather than continued experimentation with supplements.
Explore our insomnia basics and when to seek sleep help guides.
Research and Further Reading
These resources include clinical trials, medical guidelines, safety information and government educational materials.
- NIH NCCIH. Melatonin: What You Need to Know. Read source .
- Magnesium Bisglycinate Trial (2025). Randomized, placebo-controlled study in adults reporting poor sleep. Read study .
- NIH Office of Dietary Supplements. Magnesium fact sheet. Read source .
- Apigenin, Sleep and Aging (2024). Review of proposed mechanisms and available evidence. Read review .
- Glycine and Sleep Research. Human clinical-trial literature. Explore PubMed .
- L-Ornithine Trial (2014). Randomized trial examining stress markers and perceived sleep quality. Read study .
- Taurine and Sleep Research. Clinical research literature. Explore PubMed .
- American Geriatrics Society (2023). Updated Beers Criteria for potentially inappropriate medication use in older adults. Read guideline .
- Gray and colleagues (2015). Cumulative Use of Strong Anticholinergic Medications and Incident Dementia. JAMA Internal Medicine. Read study .
- DailyMed. Unisom SleepTabs drug labeling, including active ingredient and safety warnings. Read official label .
- Unisom. SleepGels product information, including diphenhydramine content. Read product information .
- NIH NCCIH. Sleep Disorders and Complementary Health Approaches. Read source .
- National Heart, Lung, and Blood Institute. Insomnia treatment. Read source .
Individual study findings may not generalize to different ages, medical conditions, formulations or doses. Evidence classifications in this guide are editorial summaries, not formal clinical guideline grades.